Understanding Pulmonary Arteriovenous Malformations After Cavopulmonary Shunts

Single-ventricle congenital heart defects demand meticulous, staged surgical interventions to optimize circulatory physiology. Therefore, pediatric cardiac surgeons frequently perform the bidirectional cavopulmonary connection, also known as the bidirectional Glenn procedure, during early infancy. However, several patients develop diffuse pulmonary arteriovenous malformations following this intermediate palliation. These abnormal vascular channels create significant intrapulmonary right-to-left shunting, which leads to progressive, severe arterial hypoxemia. Clinicians attribute this vascular pathology primarily to the exclusion of hepatic venous blood from the pulmonary circulation. Without critical hepatic factors reaching the lungs, pulmonary capillaries undergo aberrant remodeling and loss of structural resistance. Consequently, systemic cyanosis worsens, exercise capacity declines, and surgical risks escalate significantly. Although coil embolization successfully addresses discrete, focal malformations, diffuse lesions rarely respond to transcatheter interventions. Thus, pediatric cardiologists and cardiac surgeons require innovative surgical strategies to restore pulmonary vascular integrity. A promising approach involves the creation of an axillary arteriovenous fistula, which alters upper-body vascular dynamics and stimulates favorable pulmonary vascular remodeling. In addition, understanding these complex hemodynamics helps multidisciplinary teams preserve candidate eligibility for subsequent palliative milestones.

Surgical Rationale for an Axillary Arteriovenous Fistula

Creating an axillary arteriovenous fistula provides a systemic-to-pulmonary pathway that increases flow into the superior vena cava circuit. When surgeons construct this vascular connection, they introduce pulsatile, high-volume flow into the low-pressure cavopulmonary circulation. Consequently, this hemodynamic augmentation raises superior vena cava pressures and promotes enhanced microvascular recruitment across both pulmonary vascular beds. Furthermore, clinical investigators believe this increased flow stimulates endogenous angiogenesis pathways while stabilizing fragile capillary networks. Historically, severe hypoxemia caused by uncorrectable vascular channels prevented fragile children from reaching definitive Fontan completion. Fortunately, an axillary arteriovenous fistula delivers a surgically accessible solution that avoids sternotomy or cardiopulmonary bypass. Surgeons perform the peripheral anastomosis in the axillary region with relatively low procedural morbidity. In addition, the fistula enhances effective pulmonary blood flow without causing systemic ventricular overload when team members calibrate shunt dimensions accurately. Therefore, this auxiliary connection serves either as a therapeutic bridge or as durable long-term palliation for high-risk single-ventricle candidates. As surgical teams gain experience with this technique, hemodynamic parameters and arterial saturations consistently reflect substantial clinical stabilization.

Key Clinical Outcomes and Hemodynamic Improvements

A recent retrospective cohort study evaluated twelve pediatric patients who underwent fistula creation between 2014 and 2022. Importantly, all included patients completed at least six months of formal postoperative follow-up with comprehensive diagnostic monitoring. Overall, nine out of twelve patients, representing seventy-five percent of the cohort, demonstrated significant clinical and angiographic improvement. Among these responsive patients, five candidates subsequently progressed to successful total cavopulmonary connection, commonly known as the Fontan completion. Meanwhile, four patients retained the fistula as functional, long-term definitive palliation because other anatomical factors precluded subsequent surgery. Furthermore, invasive diagnostic cardiac catheterization performed after six months revealed striking physiological advances. Specifically, investigators documented statistically significant improvements in pulmonary venous oxygen saturation and aortic oxygen saturation. In addition, pulmonary artery arborization improved substantially, as evidenced by a significantly increased McGoon ratio. These objective measurements confirm that peripheral arteriovenous shunts effectively remodel pulmonary microvascular beds. Thus, the intervention mitigates right-to-left intrapulmonary shunting while providing sufficient pulmonary arterial growth for subsequent surgical stages.

Predictive Value of Early Postoperative Oxygen Saturation

Monitoring systemic oxygenation offers critical prognostic insights during the initial postoperative recovery period. Notably, the clinical trial demonstrated that arterial oxygen saturation at two months postoperatively strongly correlates with late arterial saturations. Statistical analyses confirmed significant correlations between two-month oxygen saturation and levels recorded at six, twelve, eighteen, and twenty-four months. Consequently, clinicians can reliably forecast mid-term physiological trajectory based on these early noninvasive pulse oximetry readings. If an infant displays marked improvement in oxygenation during the initial two months, favorable pulmonary vascular remodeling will likely persist. Conversely, patients who fail to achieve improved systemic saturations early might harbor refractory malformations requiring timely intervention. In clinical practice, this robust temporal correlation streamlines outpatient surveillance protocols and reduces the immediate necessity for repeated invasive cardiac catheterization. Furthermore, pediatric teams can plan the timing of completion surgeries with greater confidence. Therefore, serial noninvasive monitoring during early post-intervention visits provides essential clinical guidance for multidisciplinary pediatric cardiology teams managing complex univentricular physiology.

Clinical Implications for Single Ventricle Palliation Pathways

The development of pulmonary vascular complications remains a formidable challenge during staged surgical reconstruction for functional univentricular hearts. Because standard medical therapy offers limited benefit, clinicians often face narrow treatment options for diffuse malformations. Fortunately, this clinical evidence highlights axillary shunts as a dependable therapeutic bridge toward completion cavopulmonary anastomosis. By promoting pulmonary vascular growth and boosting arterial oxygen levels, the procedure expands surgical eligibility for otherwise high-risk children. Moreover, in patients who remain unsuitable for complete Fontan circulation, the fistula provides durable palliative stability. Pediatric cardiologists must nevertheless exercise caution before generalizing these findings across all patient subsets. Because the study evaluated a small single-center cohort, larger multicenter registries must validate these encouraging results over extended observation windows. Additionally, surgical teams must monitor potential complications, including upper extremity edema, venous hypertension, or high-output cardiac burden over time. Nevertheless, this innovative technique represents a valuable addition to the congenital cardiac armamentarium, offering renewed hope for patients facing severe, refractory cyanosis.

Frequently Asked Questions

Why do pulmonary arteriovenous malformations develop after a bidirectional cavopulmonary shunt?

Pulmonary arteriovenous malformations typically arise after a bidirectional Glenn procedure due to the diversion of hepatic venous blood away from the lungs. Under normal anatomical conditions, hepatic venous circulation carries essential biochemical substances that inhibit abnormal microvascular proliferation and maintain pulmonary capillary stability. When surgical redirection prevents these hepatic factors from perfusing the pulmonary beds, pulmonary vessels dilate uncontrollably. Consequently, abnormal right-to-left shunting develops, causing worsening arterial hypoxemia and cyanosis in affected children.

How does creating an axillary fistula improve pulmonary vascular hemodynamics?

An axillary arteriovenous fistula introduces high-velocity pulsatile systemic blood flow into the superior vena cava pathway. This augmented volume elevates hydrostatic pressure within the cavopulmonary circuit, which promotes recruitment of closed or underperfused pulmonary microvascular beds. In addition, the increased flow stimulates physiological shear stress on endothelial cells, encouraging structural vascular remodeling and pulmonary arterial expansion. Consequently, right-to-left intrapulmonary shunting decreases, systemic oxygen saturation rises, and pulmonary vessel diameters enlarge appropriately for subsequent completion surgery.

Can an axillary arteriovenous fistula serve as permanent palliation in univentricular disease?

Yes, an axillary arteriovenous fistula can function effectively as a definitive palliative intervention when completion cavopulmonary surgery remains unfeasible. While surgical teams primarily utilize this shunt as a therapeutic bridge toward total cavopulmonary connection, high pulmonary vascular resistance or complex venous anatomy sometimes precludes Fontan completion. In such scenarios, maintaining the peripheral fistula provides sustained improvements in arterial oxygenation and exercise tolerance, allowing stable functional status without proceeding to total cavopulmonary connection.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. Refer to the latest local and national guidelines for clinical practice.

References

1. Alibrahim IJ et al. Axillary Arteriovenous Fistula for Resolution of Pulmonary Arteriovenous Malformations Following Bidirectional Superior Cavopulmonary Connections. World J Pediatr Congenit Heart Surg. 2026 Sep 29. doi: 10.1177/21501351261477042. PMID: 42808974.


2. Duncan BW, Kneebone JM, Shen I, et al. Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications. Ann Thorac Surg. 2003;76(6):2024-2029.


3. Srivastava D, Preminger T, Lock JE, Mandell V. Hepatic venous factor prevents pulmonary arteriovenous malformations in single ventricle palliation. Circulation. 1995;92(10):2800-2804.